Double-contrast barium enema
A double-contrast barium enema (also called DCBE or barium enema) uses X-rays to find abnormal growths in the colon. It is a form of colorectal cancer screening.
Barium, a silver-white metallic compound, is used to outline the colon and rectum on the X-ray. Air is then passed through the same tube to further enhance the X-ray.
DCBEs are commonly used to diagnose colorectal cancer and inflammatory disease. They can also help detect polyps, diverticulitis, and structural changes in the large intestine.
Many plans cover it, socheck with your policy holder. Medicare varies, as sometimes this procedure may be substituted for a colonoscopy.
Michelle Cappel owes a lot to colorectal cancer biomarker testing — seven years of life and counting.
Don Shippey was 55 years old in 2016 when he decided he’d been putting off his colonoscopy long enough.
Takeda has announced U.S. Food and Drug Administration (FDA) approval of FRUZAQLA (fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.